key: cord-0690405-6l1rypyq
authors: Ahluwalia, Neha; Love, Barry; Chan, Alice; Zaidi, Ali N.
title: COVID-19 in an Adult with Tricuspid Atresia S/P Fontan Palliation
date: 2020-05-19
journal: JACC Case Rep
DOI: 10.1016/j.jaccas.2020.05.013
sha: 2f8f7536e506efc753825e20a439a8d520b6867a
doc_id: 690405
cord_uid: 6l1rypyq

Abstract: December 2019, a pathogenic novel human coronavirus (HCoV), termed SARS-CoV-2, was recognized in Wuhan, China causing significant morbidity and mortality. The illness caused by SARS-CoV-2 is labelled COVID-19 by WHO. We report the first case of COVID-19 in an ACHD patient with Single Ventricle (SV) physiology S/P Fontan palliation.

A 29-year-old male with a Tricuspid atresia and multiple cardiac surgical palliations with a single ventricle S/P Fontan circulation (Figure 1) , presented to the emergency room with two days of low-grade fevers, non-productive cough, easy fatigability and progressive shortness of breath. He had known exposure to a family member with COVID-19. He did not have anosmia, taste disturbances, gastrointestinal or neurological symptoms. His vital signs revealed a temperature of 38.2, heart rate 79 bpm, and SpO2 86% on room air. COVID-19 testing was positive. A chest x-ray revealed bilateral patch opacities suggestive of a pneumonic process.

Given his room air oxygen saturations were less than 94% and chest x-ray findings were consistent with a pneumonia, he was diagnosed with moderate COVID-19 infection per hospital guidelines.

His past medical history was significant for complex cyanotic congenital heart disease. He was born with Tricuspid Atresia with single ventricle physiology and had undergone multiple palliative surgeries during his childhood. His initial surgery at 3 days of life was a right classic Blalock Tausig Shunt (right subclavian artery to the pulmonary artery anastomosis). He had a Glenn procedure performed at 1 year of life, with surgical anastomosis of the right SVC to the pulmonary artery. The final cardiac surgical procedure was a lateral tunnel Fontan (IVC to pulmonary artery) performed at 4 yrs. of life. He had undergone a cardiac catheterization for systemic desaturation as a child with device closure of a large veno-venous collateral from the azygous to the left upper pulmonary vein. He had stenosis of the IVC pathway of the Fontan circuit which was treated with balloon dilation and stent placement. A work-up for recurrent epistaxis revealed a sino-nasal mass. He underwent endoscopic resection and embolization of bilateral maxillary arteries with coils and onyx through the external carotid artery. He had sporadic long term follow up with Adult Congenital Heart Disease but had no recent hospitalizations.

Though Fontan patients commonly have lower oxygen saturations between 90-95% in room air, it is important to consider other possible etiologies of systemic oxygen desaturation in a Fontan patient. One reason of baseline desaturation includes markedly deoxygenated coronary sinus vein blood that typically drains into the pulmonary venous chamber and mixes with pulmonary venous blood. Due to absent sub-pulmonic pumping ventricle, the non-pulsatile pulmonary artery blood flow tends to gravitate in lower lung segment whereas the pulmonary aeration favors upper segments resulting in ventilation-perfusion mismatch. Other differential diagnoses for desaturation in a Fontan patient include veno-venous collaterals leading to right to left shunting which allows dexogeynated venous blood to mix with oxygenated arterial blood. These veno-venous collaterals may naturally form as a "pop-off", between the high-pressure systemic venous and lower-pressure pulmonary venous chambers. These communications may develop over time, either within the heart or through extra-cardiac venous collaterals (1) . Another cause of desaturation in patients with Fontan circulation, notably those with heterotaxy syndrome is from development of pulmonary arteriovenous malformations (PAVM) causing intra-pulmonary shunting and progressive cyanosis (2) . Some Fontan patients develop plastic bronchitis caused by the spillage of protein-rich lymph through lymphatic-to-bronchial communications, which can present with productive cough, dyspnea and hypoxemia (3) . Other causes of systemic oxygen desaturation are not exclusive to patients with single ventricles, include causes that lead to hypoventilation or V/Q mismatch due to pulmonary embolism, pneumonias, asthma or COPD.

Other causes are diffusion impairments or circumstances that cause low inspired oxygen.

A chest X-ray ( Figure 2 ) showed mild bibasilar opacities at both lung bases. An EKG (Figure 3) revealed a normal sinus rhythm with a baseline RBBB, QTc interval of 460msec that was unchanged from prior. A respiratory viral panel was positive for COVID-19. Baseline labs including a complete blood count and chemistries (Table 1) CRP continued to rise with a peak value of CRP 40.3 mg/L, with an eventual decrement. The ddimer levels remained normal throughout the admission. Fibrinogen levels although normal at admission, reached a peak of 488mg/dl on day 3 of hospitalization. Liver function tests including AST/ALT were mildly elevated at admission and continued to rise with AST reaching a peak on day 7 of admission. Similarly, ALT peaked on day 9 of admission. By discharge, the transaminase levels were down-trending (Figure 4 ). An abdominal US showed normal liver size (15.5 cm) with increased liver echogenicity and a nodular contour suggestive of liver fibrosis, likely due to Fontan Associated Liver Disease (FALD). His CBC was trended with normalization of his platelet count by day 6 of hospitalization.

In the ER, the patient was hypoxic with oxygen saturations of 86% on RA with accompanying dyspnea. He was placed on 4L-6L of oxygen via a nasal cannula which led to an improvement in the oxygen saturations to low 90's. High-flow nasal cannula (HFNC) was attempted which he did not tolerate. He continued to need supplemental oxygen till day 6 of his hospitalization.

There was no need for mechanical ventilation. Aggressive intensive spirometry was encouraged.

He was seen by the COVID-19 Infections Disease Team and was started on hydroxychloroquine (400 mg PO BID for 1 day, then 400 mg PO daily to complete a 5-day course). A daily EKG was performed which did not show prolongation of his QTc interval. A five-day PO course of azithromycin was also given. He was aggressively diuresed with intravenous furosemide. A PDE5i (Sildenafil) 20 mg PO TID was started. With the initiation of Sildenafil, there was a slow improvement in his clinical symptoms. Subcutaneous heparin for DVT prophylaxis was started which was later switched to full dose Lovenox. The patient was hospitalized for ten days and discharged in stable condition on Aspirin 81 mg po daily and Sildenafil.

There has been no published data on the impact of COVID-19 on adults with a congenital heart defect. This is the first case report of an adult congenital heart disease patient with single Another important aspect of COVID-19 is the presence of abnormal coagulation profile, leading to formation of micro-thrombi, and when combined in a patient with low flow circuit like Fontan circulation the outcomes can be catastrophic. The incidence of venous thromboembolism among COVID-19 patients in critically sick patients who are in the Intensive Care Unit appears to be somewhat higher compared to that reported in other studies including such patients with other disease conditions. D-dimer might help in early recognition of these high-risk patients and also predict outcome. Our patient did not have elevated D-dimer through his admission. There is also preliminary data in patients with severe COVID-19, anticoagulant therapy appears to be associated with lower mortality in the subpopulation meeting sepsis-induced coagulopathy criteria or with markedly elevated d-dimer (9) . The predominant predisposing factor is venous stasis which is often evident in the cavo-pulmonary circuit in light of the absence of a pump for systemic venous return and pulmonary blood flow. It is now well known, that adult patients with Fontan palliation should be considered for long term anticoagulation (10) .

Patients with underlying liver disease and those after liver transplantation represent vulnerable patient cohorts with an increased risk of infection and/or a severe course of COVID-19 (11) .

Liver involvement in patients with Fontan circulation (also called Fontan Associated Liver Disease or FALD) is well reported and the pathogenesis includes elevated central venous pressure, lymphatic congestion and decreased cardiac output. Manifestation of FALD can manifest as mild elevated of transaminases (AST and ALT), with numerous studies showing that Fontan patients on long term follow up had demonstrated at least 1 serological liver abnormality with elevated GGT (γ-glutamyl transferase) being the most common (12) . This patient had modest transaminitis likely due the effects of COVID-19 on his underlying FALD (13) .

The patient was discharged after a ten-day hospitalization. At time of discharge his oxygen saturations had improved to 92-94% on room air which was his baseline. His symptoms of shortness of breath had completely resolved. Due to his transaminitis with concerns for FALD, he was scheduled for elective hepatic magnetic resonance elastography derived liver stiffness (MRE-LS) to evaluate for the extent of underlying liver fibrosis (14).

The COVID-19 pandemic has acutely impacted patients with underlying medical conditions. Evaluation and care by ACHD specialists are mandatory in optimizing management strategies for adults with complex congenital heart disease with COVID-19.

Understanding the baseline hemodynamics in Fontan patients when managing COVID-19 infection. 

Characterization and treatment of systemic venous to pulmonary venous collaterals seen after the Fontan operation

Hepatic Venous Blood and the Development of Pulmonary Arteriovenous Malformations in Congenital Heart Disease

Successful treatment of plastic bronchitis by selective lymphatic embolization in a Fontan patient

Hemodynamic response to positive end-expiratory pressure following right atrium-pulmonary artery bypass (Fontan procedure)

Drug therapy in the prevention of failure of the Fontan circulation: a systematic review

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

Cyclosporin-induced endothelial dysfunction and hypertension: are nitric oxide system abnormality and oxidative stress involved?

Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology

Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action

Clinical Importance of Fontan Circuit Thrombus in the Adult Population: Significant Association With Increased Risk of Cardiovascular Events

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart (British Cardiac Society)

COVID-19 and the liver: little cause for concern

Temporal changes in liver stiffness after Fontan operation: Results of serial magnetic resonance elastography